Position in ZTS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$14,744,378
-$9,996,620 QoQ
Shares Held
205,182
-2.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#189
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HERITAGE INVESTORS MANAGEMENT CORP holds $21,531,235 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (68.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
205,182 | $14,744,378 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
114,247 | $2,811,618 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
43,543 | $1,475,236 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,939 | $1,313,482 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
7,040 | $1,186,521 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,744,378 | 205,182 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $24,740,998 | 209,297 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $25,768,061 | 204,801 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $29,293,849 | 200,204 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $30,639,028 | 196,467 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $32,121,403 | 195,089 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $30,158,994 | 185,104 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $34,927,496 | 178,767 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $31,472,467 | 181,544 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $29,405,990 | 173,784 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $34,052,246 | 172,530 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $30,094,364 | 172,976 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $29,991,749 | 174,158 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $28,631,841 | 172,025 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $25,172,893 | 171,770 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $24,452,131 | 164,894 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $27,946,907 | 162,586 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $30,487,459 | 161,660 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $38,686,563 | 158,532 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $31,585,413 | 162,694 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $30,992,972 | 166,307 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $27,374,275 | 173,827 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $28,673,371 | 173,253 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $29,239,731 | 176,814 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $25,468,198 | 185,845 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $22,276,833 | 189,284 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||